LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
Do not use preservative. Preservatives used for routine analysis may contain mercuric oxide (ie, Stabilur), which interferes with all metal testing. If both urinalysis and metal testing are ordered, please submit a separate urine specimen (containing no additive) for the metal testing.
2 - 3 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Plastic urine container, no preservative
Maintain specimen at room temperature.
Confirm manganese exposure, toxicity, or poisoning by documenting excessive urine excretion of the metal. Also used to individualize manganese dosing in long-term parenteral nutrition, especially in liver disease, when biliary excretion is low, or when there is excessive gastrointestinal losses, such as in short bowel syndrome. Has been used to follow the success of chelation therapy with para-aminosalicylate sodium in manganism.
Levels in urine are so low that considerable error may be introduced by contamination. Manganese toxicity may leave residual neurologic damage after serum and urine levels have returned to normal, masking the original cause.
This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.
Inductively-coupled plasma/mass spectrometry (ICP/MS)
Environmental exposure: 0.0−2.9 μg/L1
Manganese poisoning through acute exposure may produce symptoms of fever, muscle pains, chills, and dryness of the mouth and throat. Chronic exposures to manganese may be evidenced by effects on the CNS (eg, headache, restlessness, irritability, personality change, hallucinations, and hearing impairment).2 Levels may be reduced mildly in epilepsy and raised in hepatitis or jaundice.3 Urine manganese is used in conjunction with plasma manganese to evaluate possible toxicity or deficiency of manganese, an essential mineral. High concentrations can cause nausea, headache, and psychiatric disturbances with neurological damage similar to Parkinson disease. Normalization of plasma may not reverse the neurological damage.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|071597||Manganese, Urine||071598||Manganese, Urine||ug/L||5684-6|
|071597||Manganese, Urine||071599||Manganese/Crt Ratio||ug/g creat||27367-2|
© 2020 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf